120 related articles for article (PubMed ID: 38841157)
1. Clinicopathological characteristics and prognosis of synchronous brain metastases from non-small cell lung cancer compared with metachronous brain metastases.
Li J; Zhang X; Wang Y; Jin Y; Song Y; Wang T
Front Oncol; 2024; 14():1400792. PubMed ID: 38841157
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and survival outcomes of synchronous and metachronous brain metastases: a retrospective population-based study.
Jiang K; Parker M; Materi J; Azad TD; Kamson DO; Kleinberg L; Ye X; Rincon-Torroella J; Bettegowda C
Neurosurg Focus; 2023 Aug; 55(2):E3. PubMed ID: 37527669
[TBL] [Abstract][Full Text] [Related]
3. Lung-molGPA Index Predicts Survival Outcomes of Non-Small-Cell Lung Cancer Patients with Synchronous or Metachronous Brain Metastases.
Chen K; Zhang F; Fan Y; Cheng G
Onco Targets Ther; 2020; 13():8837-8844. PubMed ID: 32943887
[TBL] [Abstract][Full Text] [Related]
4. Metachronous Brain Metastasis in patients with EGFR-mutant NSCLC indicates a worse prognosis.
Ouyang W; Yu J; Zhou Y; Xu Y; Li J; Gong J; Zhang J; Xie C
J Cancer; 2020; 11(24):7283-7290. PubMed ID: 33193892
[No Abstract] [Full Text] [Related]
5. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
[TBL] [Abstract][Full Text] [Related]
6. Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer.
Ouyang W; Yu J; Zhou Y; Hu J; Huang Z; Zhang J; Xie C
BMC Cancer; 2020 Jul; 20(1):699. PubMed ID: 32723319
[TBL] [Abstract][Full Text] [Related]
7. Survival after resection of brain metastasis: impact of synchronous versus metachronous metastatic disease.
Potthoff AL; Heimann M; Lehmann F; Ilic I; Paech D; Borger V; Radbruch A; Schäfer N; Schuss P; Vatter H; Herrlinger U; Schneider M
J Neurooncol; 2023 Feb; 161(3):539-545. PubMed ID: 36695975
[TBL] [Abstract][Full Text] [Related]
8. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and outcome of surgically treated patients with brain metastases of non-small cell lung cancer.
She C; Wang R; Lu C; Sun Z; Li P; Yin Q; Liu Q; Wang P; Li W
Thorac Cancer; 2019 Feb; 10(2):137-142. PubMed ID: 30485664
[TBL] [Abstract][Full Text] [Related]
10. Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram.
Ji X; Zhuang Y; Yin X; Zhan Q; Zhou X; Liang X
BMC Cancer; 2017 Nov; 17(1):774. PubMed ID: 29157203
[TBL] [Abstract][Full Text] [Related]
11. Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: An Australian multicenter study.
Ha FJ; Spain L; Dowling A; Kwan EM; Pezaro C; Day D; Chia PL; Tran B; Pook D; Weickhardt AJ
Asia Pac J Clin Oncol; 2019 Oct; 15(5):e97-e102. PubMed ID: 30701671
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma.
Choi SY; Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
Clin Genitourin Cancer; 2017 Dec; 15(6):717-723. PubMed ID: 28552571
[TBL] [Abstract][Full Text] [Related]
13. Survival Benefit from Surgical Resection in Lung Cancer Patients with Brain Metastases: a Single-Center, Propensity-Matched Analysis Cohort Study.
Wang ZN; Jiang XB; Lu J; Guo XY; He ZQ; Duan H; Liang L; Cui R; Hu HR; Zhang XH; Zhong S; Li C; Yu CW; Guo CC; Mou YG
Ann Surg Oncol; 2022 Jun; 29(6):3684-3693. PubMed ID: 35181815
[TBL] [Abstract][Full Text] [Related]
14. Timing of Development of Symptomatic Brain Metastases from Non-Small Cell Lung Cancer: Impact on Symptoms, Treatment, and Survival in the Era of Molecular Treatments.
Jünger ST; Schödel P; Ruess D; Ruge M; Brand JS; Wittersheim M; Eich ML; Schmidt NO; Goldbrunner R; Grau S; Proescholdt M
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33287226
[TBL] [Abstract][Full Text] [Related]
15. Exon 19 deletion of epidermal growth factor receptor is associated with prolonged survival in brain metastases from non-small-cell lung cancer.
Li H; Zhang X; Cao J; Su P; Lian J; Song X; Yang W; Han S; Xi Y; Wang Y
Tumour Biol; 2015 Dec; 36(12):9251-8. PubMed ID: 26091796
[TBL] [Abstract][Full Text] [Related]
16. Targeted Therapies and Utility of the Lung-molGPA in Non-Small-Cell Lung Cancer Patients with Brain Metastases.
Cacho-Díaz B; Cuapantécatl LD; Garcilazo-Reyes YJ; Cabrera-Miranda L; Hernandez-Martinez JM; Arrieta O
Oncology; 2022; 100(10):542-554. PubMed ID: 35988535
[TBL] [Abstract][Full Text] [Related]
17. Clinical Features of Precocious, Synchronous, and Metachronous Brain Metastases and the Role of Tumor Resection.
Shibahara I; Kanamori M; Watanabe T; Utsunomiya A; Suzuki H; Saito R; Sonoda Y; Jokura H; Uenohara H; Tominaga T
World Neurosurg; 2018 May; 113():e1-e9. PubMed ID: 29104152
[TBL] [Abstract][Full Text] [Related]
18. Analyses of prognostic factors in cases of non-small cell lung cancer with multiple brain metastases.
Gong X; Zhou D; Liang S; Zhou C
Onco Targets Ther; 2016; 9():977-83. PubMed ID: 27042095
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for brain metastases from non-small cell lung cancer with EGFR mutation: influence of stable extracranial disease and erlotinib therapy.
Sekine A; Satoh H; Iwasawa T; Tamura K; Hayashihara K; Saito T; Kato T; Arai M; Okudela K; Ohashi K; Ogura T
Med Oncol; 2014 Oct; 31(10):228. PubMed ID: 25208818
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment.
Getman V; Devyatko E; Dunkler D; Eckersberger F; End A; Klepetko W; Marta G; Mueller MR
Eur J Cardiothorac Surg; 2004 Jun; 25(6):1107-13. PubMed ID: 15145017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]